Arkema SA

AKE: XPAR (FRA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
€721.00HqvgNdftpxst

Arkema Beats Q3 Estimates and Confirms 2022 Guidance; Shares Undervalued

No-moat Arkema reported third-quarter EBITDA of EUR 495 million, up 4% over 2021 and slightly above the company-compiled consensus. Guidance for 2022 EBITDA of EUR 2.1 billion was maintained despite some destocking expected in the fourth quarter with the economy slowing, particularly in Europe. We don’t expect to make a material change to our EUR 105 fair value estimate. At current levels, the shares look undervalued.

Sponsor Center